Clinical Trials Logo

Orthostatic Hypotension clinical trials

View clinical trials related to Orthostatic Hypotension.

Filter by:

NCT ID: NCT00004478 Completed - Clinical trials for Orthostatic Hypotension

Droxidopa in Treating Patients With Neurogenic Hypotension

Start date: March 1999
Phase: N/A
Study type: Interventional

Please note that the continuation study can be found at http://clinicaltrials.gov/show/NCT00633880. RATIONALE: Neurogenic hypotension is a fall in blood pressure that occurs when one moves from a lying down to a standing position or after eating a meal. It causes one to feel dizzy, light headed, and weak. Neurogenic hypotension is caused by a problem in the part of the nervous system that controls such functions as heart rate and blood pressure. Droxidopa, a drug that may increase blood pressure, may be an effective treatment for neurogenic hypotension. PURPOSE: Clinical trial to study the effectiveness of droxidopa in treating patients who have neurogenic hypotension.

NCT ID: NCT00004268 Completed - Clinical trials for Orthostatic Hypotension

Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension

Start date: April 2001
Phase: Phase 2
Study type: Interventional

OBJECTIVES: I. Study further the safety and efficacy of the alpha-receptor agonist midodrine in patients with neurogenic orthostatic hypotension. II. Assess the quality of life in these patients with this treatment regimen.